PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-04-29

Date Title Company
29-Apr-2025 Evotec SE to announce results for the first quarter 2025 on 6 May 2025 Evotec SE
29-Apr-2025 CBD Life Sciences Inc. (CBDL) Announces New Manufacturing Deal With A Columbian Company ACCESS Newswire
29-Apr-2025 Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System ACCESS Newswire
29-Apr-2025 Invitation to the Presentation of Cantargia's Interim Report for Q1 2025 ACCESS Newswire
29-Apr-2025 M1 Kliniken AG publishes preliminary figures for the 2024 financial year: Strong EBIT growth (+70%) and significant increase in earnings per share (+57%) M1 Kliniken AG
29-Apr-2025 Measles is Likely to Become Endemic - NanoViricides Is Testing a Drug to Combat It ACCESS Newswire
29-Apr-2025 BioInvent Receives FDA Fast Track Designation for BI-1808 for the Treatment of Cutaneous T-cell Lymphoma ACCESS Newswire
29-Apr-2025 Monogram Technologies Granted Regulatory Approval to Import mBôs TKA System for Clinical Investigation in India ACCESS Newswire
29-Apr-2025 AEVIS VICTORIA SA (AEVS.SW) – MRH Switzerland's positive momentum continues in the first quarter of 2025, driven by the operational excellence of its flagship establishments AEVIS VICTORIA SA
29-Apr-2025 Evotec SE to Announce Results for the First Quarter 2025 on 6 May 2025 ACCESS Newswire
29-Apr-2025 The Healthcare Impact Alliance Expands Connected Healthcare Ecosystem With Mendock Technology Smart Lock Integration ACCESS Newswire
29-Apr-2025 Senzime Secures New TetraGraph Contract with State-Wide University Hospital System in Southern US ACCESS Newswire
29-Apr-2025 BioInvent International AB: Interim Report January - March 2025 ACCESS Newswire
29-Apr-2025 XVIVO Presents 12-Month Follow-Up Results from European Multicenter Heart Transplantation Trial at ISHLT in Boston ACCESS Newswire
29-Apr-2025 Cantargia Announces Selection of Treatment Resistant Atopic Dermatitis as Second Target Indication for CAN10 ACCESS Newswire